14 March 2022 - Newsletter

Diagnostics specialist numares AG concludes licence agreement with the University of Oxford

In the development of an urgently needed in-vitro diagnostic test for multiple sclerosis, numares AG relies exclusively on the scientific preliminary work of the University of Oxford. numares works with AI and develops multimarker algorithms for diagnostic tests. With the help of the new MS tests, the transitions between different stages of the disease in particular are to be diagnosed in good time in order to be able to initiate adequate treatment for MS patients.

More information: https://t1p.de/kd8w